<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2429</article-id><article-id pub-id-type="doi">10.7324/IJCRR.2017.1032</article-id><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Albendazole Resistant Neurocysticercosis- Rare Unusual Case Report&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Meena</surname><given-names>Rattilal</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mittal</surname><given-names>Ankur</given-names></name></contrib><contrib contrib-type="author"><name><surname>Samar</surname><given-names>Neera</given-names></name></contrib><contrib contrib-type="author"><name><surname>Prajapati</surname><given-names>Mehul</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>1</day><month>02</month><year>2018</year></pub-date><volume>)</volume><issue/><fpage>7</fpage><lpage>9</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>A 25 years old female patient presented with history of recurrent seizures since 2 years. Patient was diagnosed as a case of Neurocysticercosis based on Magnetic resonant imaging (MRI) of brain finding in January 2015 for which she was given a course of Albendazole, Prednisolone and antiepileptic medications. During the following 2 year period, patient developed recurrent seizures and abnormal behavior for which patient was investigated and new neurocysticercosis lesions were found in MRI Brain despite previous complete antiparasitic treatment and adherence to diet and antiepileptic medication. Patient had received courses of Albendazole (4 times) with combination of Ivermectin (1 time), and with course of Praziquantel (1 time). So we are reporting this rare case of neurocysticercosis resistant to conventional, routinely used antihelminthic medications.&#13;
</p></abstract><kwd-group><kwd>Neurocycticercosis</kwd><kwd> Albendazol resistance</kwd><kwd> Praziquantel</kwd><kwd> Seizure</kwd><kwd> Antihelminthic</kwd></kwd-group></article-meta></front></article>
